EuroMedtech EBD Group EuroMedtech
Email this page Share this on LinkedIn Share this on Twitter

EuroMedtech™ 2014 Press Releases

May 15, 2014EuroMedtech™ 2014 reports an 82% increase in licensable assets and technologies brought to partner The sixth annual EuroMedtech partnering conference, held May 7–8, 2014, wrapped up in Linz, Austria last week. The event reported an 82% increase in licensing opportunities at the event, indicating a surge in medtech innovation and the increasing role of collaboration in medtech industry business strategies. "The event was buzzing with activity this year, with substan...  more ►

April 22, 2014EuroMedtech™ 2014 presenting companies bring cutting edge medical technologies to potential partners The sixth annual EuroMedtech partnering conference will be held May 7–8, 2014 in Linz, Austria. EuroMedtech is Europe's leading medical technology partnering conference, providing collaboration opportunities to medtech decision makers and investors. The Presenting Companies track provides a pipeline to innovative companies interested in partnering their technologies...  more ►

April 1, 2014EuroMedtech™ 2014 announces pre-conference business development workshop and May 8 special Diagnostics session The sixth annual EuroMedtech partnering conference will be held May 7–8, 2014 in Linz, Austria. EuroMedtech is Europe's leading medical technology partnering conference, providing collaboration opportunities to medtech decision makers and investors. A pre-conference Business Development Workshop entitled "Effective Innovation Portfolio Management for Medical Device ...  more ►

March 26, 2014Spotlight on Linz Business Facts A top European location for health technology: From blood sugar tests to wheelchairs, CT scanners to syringes—medical technology companies in Austria can be found in each and every specialized field of the sector. A thriving medical technology economy: A total of 433 companies in the Upper Austrian region can be related in one way or another to the field of medical techn...  more ►

February 6, 2014EuroMedtech™ 2014 brings leaders in medical device innovation to Linz, Austria this May The sixth annual EuroMedtech 2014 partnering conference will be held May 7–8, 2014 in Linz, Austria. EuroMedtech is Europe's leading medical technology partnering conference where participants engage with potential partners around in- and out-licensing of products and IP, financing and other collaborative programs. The 2013 event attracted 261 dealmakers from 191 comp...  more ►

partnering360® Blog

January 29, 2015 Online engagement tools put drug developers in touch with patients Getting life saving and innovative drugs to market is a big job. It starts with ground breaking science, built upon decades of discovery and failure, and from the moment of promise involves years, decades even, of negotiations, funding rounds and partnerships. It can be hard to keep the original... more ►

January 26, 2015 Spotlight on the MedTech Industry The Medtech Trends and MoneyTree™ Investment Data report has recently been published and the medtech industry is profiting from more deals – however, the number of medtech companies receiving actual investment is down – so the fewer companies that are seeing investment are seeing more... more ►

January 23, 2015 Recursion Pharmaceuticals: Innovative alternative to drug discovery Investment in biotech companies is increasing.  A recent article at Drug Discovery and Development shares that biotech investing was up 26% at the beginning of 2014 which equaled $2.93 billion.  Many believe it is because investments are shifting from digital to problems that need to be solved on... more ►

January 14, 2015 Biotech Showcase™ 2015 Day Three Biotech Showcase™ 2015 day three started off with the panel “Apps as drugs” moderated by Steve Dickman of CBT Advisors which gave insight into online and mobile apps and programs that augment disease platforms. There was interest in whether the apps would replace or work in conjunction with... more ►

January 14, 2015 Biotech Showcase™ 2015: Days 1 and 2 Highlights Biotech Showcase™ 2015 is in full swing on this second conference day. An estimated 2,100 delegates have been participating in 4,400 one-to-one partnering meetings this year, an all-time high. The Alliance for Regenerative Medicine’s (ARM)“Regenerative Medicine and Advanced Therapies State of... more ►

partnering360:Insight Latest headlines from partnering360:Insight

January 30, 2015 2015 JP Morgan Conference Highlights The annual J.P. Morgan Healthcare Conference wrapped up earlier this month in San Francisco with a huge gathering of biotech and pharma companies coming together to discuss pipelines, partnerships, and promises for the new year. Below are highlights from this year’s conference taken from BioMedTracker and MedDeviceTracker’s 2015 JP Morgan Healthcare Conference Highlights report. One notable highlight was more ►

January 22, 2015 Life sciences democratize research and investing Non-accredited investors are beginning to have the opportunity to invest in biotech, thanks to some innovative new financing mechanisms and the growing democratization of healthcare, according to panelists at the Biotech Showcase™ 2015 financing session. more ►

January 16, 2015 Are old financing models enough? Last year saw more than USD 400 billion returned to investors through IPO exits and a bevy of new venture funds created, but this doesn’t signal a return to business as usual. Instead biotech financing in the future must continue to look to innovative strategies and must address reimbursement questions ever earlier in the race to attract funds, according to panelists at a Biotech Showcase™ 2015 lunch plenary. more ►

January 16, 2015 Regenerative medicine creating tangible value Regenerative medicine is beginning to add real value to healthcare not just by treating disease, but by curing disease. Most people—even those in the industry—don’t realize that more than 60 regenerative products have been approved, said Edward Lanphier. Some 500 companies are operating in this space globally, with 375 ongoing clinical trials. Of those, 340 are in Phase I or Phase II. Therefore, a great many products can be expected to be commercialized in the next few years. more ►

January 16, 2015 Perceptions of value and success There’s no single definition of value in the life sciences. Big pharma, investment bankers and venture capitalists each have different goals that affect their perception of value and guide their investment decisions. Panelists at a luncheon plenary session at Biotech Showcase™ 2015 made that point patently evident. more ►

Arrow Up

See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2015 EBD GmbH
Privacy Policy
Terms of Use
EuroMedtech EBD Group EuroMedtech